163 related articles for article (PubMed ID: 4612507)
1. [L-thyroxine propylhexedrine in the treatment of obesity. Crossed double blind study].
González Barranco J; Rull JA; Lozano Castañeda O
Prensa Med Mex; 1974; 39(5-6):298-9. PubMed ID: 4612507
[No Abstract] [Full Text] [Related]
2. Controlled clinical evaluation of a new anorectic agent in obese adults.
Elmaleh MK; Miller J
Pa Med; 1974 Sep; 77(9):46-50. PubMed ID: 4609056
[No Abstract] [Full Text] [Related]
3. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
Defelice EA; Chaykin LB; Cohen A
Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
[No Abstract] [Full Text] [Related]
4. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
Bienert HR; Uberla K
Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
[No Abstract] [Full Text] [Related]
5. Evaluation of a new anorexic agent in adolescence.
Bauta HP
Conn Med; 1974 Sep; 38(9):460-3. PubMed ID: 4606529
[No Abstract] [Full Text] [Related]
6. Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.
De Felice EA; Bronstein S; Cohen A
Curr Ther Res Clin Exp; 1969 May; 11(5):256-62. PubMed ID: 4977396
[No Abstract] [Full Text] [Related]
7. Preliminary clinical evaluation of a new appetite suppressant. A double-blind study.
Feldman HS
J Med Soc N J; 1966 Oct; 63(10):454-7. PubMed ID: 5341753
[No Abstract] [Full Text] [Related]
8. A new anorexiant. Clinical evaluation.
Smith DE
Rocky Mt Med J; 1974 Jan; 71(1):41-4. PubMed ID: 4131377
[No Abstract] [Full Text] [Related]
9. Diethylpropion hydrochloride: an effective appetite suppressant.
Bolding OT
Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
[No Abstract] [Full Text] [Related]
10. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
Truant AP; Olon LP; Cobb S
Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
[No Abstract] [Full Text] [Related]
11. A double blind controlled trial of a new anorectic agent AN448.
Woodhouse SP; Nye ER; Anderson K; Rawlings J
N Z Med J; 1975 Jun; 81(542):546-9. PubMed ID: 1099491
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
[No Abstract] [Full Text] [Related]
13. Double-blind trial of anorectic agents.
Sproule BC
Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
[No Abstract] [Full Text] [Related]
14. Obesity-depression: clinical evaluation with a new anorexigenic agent.
Kornhaber A
Psychosomatics; 1973; 14(3):162-7. PubMed ID: 4604838
[No Abstract] [Full Text] [Related]
15. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties.
Elliott BW
Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837
[No Abstract] [Full Text] [Related]
16. A clinical trial of fenfluramine.
Traherne JB
Practitioner; 1965 Nov; 195(169):677-80. PubMed ID: 5321366
[No Abstract] [Full Text] [Related]
17. Weight reduction with phenmetrazine and chlorphentermine a double-blind study.
Hadler AJ
Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505
[No Abstract] [Full Text] [Related]
18. Controlled trial of a new anorectic drug in the treatment of obesity.
Silverstone JT; Solomon T; Ross M; Kelly T
Br J Clin Pract; 1967 Jul; 21(7):337-9. PubMed ID: 4859981
[No Abstract] [Full Text] [Related]
19. [Effect of Cafilon in the treatment of obesity (author's transl)].
Honzák R; Rath R; Vondra K
Cesk Gastroenterol Vyz; 1976 Apr; 30(3):155-61. PubMed ID: 1277334
[No Abstract] [Full Text] [Related]
20. [Clinically controlled trial of Perphoxene].
Barbey JD
Schweiz Rundsch Med Prax; 1971 Sep; 60(37):1242-6. PubMed ID: 4937701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
